CB
51
-6
CI
33
-5
HCA
70
4
MA
72
-2
KMX
52
2
NSC
71
4
MMC
58
-4
BAC
69
4
AN
65
2
AMZN
66
2
JNJ
53
-4
GT
50
3
DGX
46
-2
BRK.B
36
-2
NEM
53
-2
FDX
58
-2
LYB
23
-4
ITW
48
-2
KMI
73
2
GOOGL
54
6
CB
51
-6
CI
33
-5
HCA
70
4
MA
72
-2
KMX
52
2
NSC
71
4
MMC
58
-4
BAC
69
4
AN
65
2
AMZN
66
2
JNJ
53
-4
GT
50
3
DGX
46
-2
BRK.B
36
-2
NEM
53
-2
FDX
58
-2
LYB
23
-4
ITW
48
-2
KMI
73
2
GOOGL
54
6
Financhill
Back

Citizens Financial Services Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Buy
67

CZFS
Citizens Financial Services

Last Price:
$59.50
Seasonality Move:
-1.1%
Sell
40

RYTM
Rhythm Pharmaceuticals

Last Price:
$56.77
Seasonality Move:
54.9%
Buy
67
Citizens Financial Services (CZFS) is a Buy

Is Citizens Financial Services a Buy, Sell or Hold?

  • The current Citizens Financial Services [CZFS] share price is $59.49. The Score for CZFS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • CZFS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Rhythm Pharmaceuticals (RYTM) is a Sell

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $56.79. The Score for RYTM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CZFS Stock Price Chart

What is Citizens Financial Services's stock price today?

  • The Citizens Financial Services share price today is $59.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CZFS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $56.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.

CZFS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 58.98 Buy
Chaikin Money Flow: 7763 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.64 - 57.62) Buy
Bollinger Bands (100): (56.25 - 62.71) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 42.6 Sell
Chaikin Money Flow: -624535 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.84 - 63.98) Sell
Bollinger Bands (100): (52.91 - 60.75) Sell

CZFS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.47 Buy
20-day SMA: 56.43 Buy
50-day SMA: 56.96 Buy
200-day SMA: 59.01 Buy
8-day EMA: 57.46 Buy
20-day EMA: 56.82 Buy
50-day EMA: 57.47 Buy
200-day EMA: 58.05 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.2 Sell
20-day SMA: 61.98 Sell
50-day SMA: 56.81 Sell
200-day SMA: 54.3 Buy
8-day EMA: 60.2 Sell
20-day EMA: 60.6 Sell
50-day EMA: 58.68 Sell
200-day EMA: 53.71 Buy

Citizens Financial Services Earnings Growth & CZFS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.09 per share, an increase this year of $1.23 per share, and an increase next year of $0.21 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.

Citizens Financial Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):